Vaccine Ontology
7398 terms(s) returned
| Term Type: | Record: 6351 to 6400 of 7398 Records | Page: 128 of 148, First Previous Next Last | Show Records Per Page |
- malaria vaccine
- male biological sex datum
- manA from B. melitensis
- manB from B. melitensis
- marker vaccine
- mce-2 from Mycobacterium tuberculosis
- mce-3 from Mycobacterium tuberculosis
- measles virus vaccine vector
- melanoma vaccine
- meningococcal A polysaccharide vaccine (non-US)
- meningococcal AC polysaccharide vaccine (non-US)
- meningococcal ACWY vaccine unspecified formulation
- meningococcal B unspecified formulation
- meningococcal C conjugate vaccine
- meningococcal conjugate vaccine
- meningococcal group A polysaccharide
- meningococcal group A polysaccharide 0.1 MG/ML
- meningococcal group A polysaccharide 0.1 MG/ML / meningococcal group C polysaccharide 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP W-135 0.1 MG/ML / MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP Y 0.1 MG/ML [Menomune A/C/Y/W-135]
- meningococcal group B vaccine
- meningococcal group B vaccine 0.1 MG/ML
- meningococcal group B vaccine 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen 0.1 MG/ML / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle 0.05 MG/ML [Bexsero]
- meningococcal group B vaccine Injectable Product
- meningococcal group B vaccine Prefilled Syringe
- meningococcal group B vaccine Prefilled Syringe [Bexsero]
- meningococcal group C polysaccharide
- meningococcal group C polysaccharide 0.01 MG/ML
- meningococcal group C polysaccharide 0.1 MG/ML
- meningococcal polysaccharide (groups A C Y W-135) tetanus toxoid conjugate vaccine 0.5mL dose preservative free
- meningococcal vaccine of unknown formulation and unknown serogroups
- mesothelioma cancer vaccine
- metH from Neisseria meningitidis
- mic2 from Toxoplasma gondii
- microbial derivative vaccine adjuvant
- microbial eukaryotic vaccine
- microencapsulated B. melitensis mutant vaccine
- microencapsulated Caf1 and LcrV vaccine
- mineral salt vaccine adjuvant
- mntA from Bacillus anthracis
- modification of adaptive immune response to antigen
- modified Y. pestis with TLR4-stimulating LPS
- monophosphoryl lipid A vaccine adjuvant
- monosodium glutamate stabliizer
- monthly
- mouse Ifng
- mouse gene
- mouse/human gp10025-33 peptide plus CpG adjuvant; mouse/human gp100; mouse/human gp10025-33 peptide-pulsed DCs vaccine
- msbB from Salmonella Typhimurium
- msbB2 from Shigella
- mucR from B. melitensis
- mucosal immune response to vaccine
